
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Preclinical
Sponsor : Labskin Limited
Deal Size : $2.0 million
Deal Type : Collaboration
Genvira and Labskin Receive £1.2 Million UK–Canada Collaboration Award
Details : As part of the collaboration, Labskin will utilize its expertise in advanced disease modeling to develop a novel 3D human skin model of melanoma, enabling in vitro testing of vaccine candidates.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Undisclosed
July 31, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Preclinical
Sponsor : Labskin Limited
Deal Size : $2.0 million
Deal Type : Collaboration
